Effect of Tourniquet Binding of Cervical on the Blood Volume of Amniotic Fluid in Cesarean Section
Launched by FIRST PEOPLE'S HOSPITAL OF CHENZHOU · Feb 8, 2024
Trial Information
Current as of June 28, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a technique called tourniquet binding, which is applied to the neck area after a baby is delivered during a cesarean section. Researchers want to see if this method can help reduce the amount of amniotic fluid that enters the mother's bloodstream. This is important because too much amniotic fluid in the bloodstream can lead to complications during surgery, such as amniotic fluid embolism and pulmonary hypertension.
To participate in this study, women must be pregnant with only one baby and in good health, meaning they should not have high blood pressure or heart disease. They also need to have no conditions that would complicate surgery, such as certain problems with the placenta or previous abdominal surgeries. Participants will need to provide consent, meaning they understand the study and agree to take part. The study is currently not recruiting participants yet, but it's designed to help improve safety for women undergoing cesarean sections.
Gender
FEMALE
Eligibility criteria
- • Inclusion criteria
- • 1. Single pregnancy
- • 2. Be in good health, with no high blood pressure or heart disease during pregnancy
- • 3. Without placenta previa and placenta implantation
- • 4. No abdominal adhesions, suitable for operation
- • 5. Signed informed consent by the pregnant woman and her family
- • Exclusion criteria
- • 1. Serious coagulation abnormality
- • 2. Preoperative severe cardiac, cerebral, pulmonary, hepatic, renal and other important organs insufficiency and electrolyte abnormality combined with placenta praevia or placenta implantation
- • 3. Multiple pregnancies
- • 4. Previous history of abdominal surgery
- • 5. Intraoperative drug allergy
About First People's Hospital Of Chenzhou
First People's Hospital of Chenzhou is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a robust research framework, the hospital collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct high-quality clinical studies. Its state-of-the-art facilities and adherence to stringent ethical standards ensure that clinical trials are executed with the utmost integrity and scientific rigor, making it a pivotal contributor to the advancement of medical knowledge and therapeutic options in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chenzhou, Hunan, China
Patients applied
Trial Officials
Zhiming zhang
Principal Investigator
Chenzhou NO. 1 people's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported